Experiments for taxon Aspergillus terreus (HYPHOMYCETES)

Experiments (70 results)

Filters
Worktypes (29)
18
18
15
14
14
12
12
9
6
6
5
5
4
4
4
3
2
1
1
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (17)
8
5
2
2
2
2
1
1
1
1
1
1
1
1
1
1
39
No match
Compounds (43)
10
7
5
4
4
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
9
No match
Organisms (37)
9
7
6
4
4
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
70 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
1145333
PHARMACOLOGY OF COMPOUND - IN VIVO
DIABETOGENIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
1310355
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLIN DEPENDENT KINASE 1 INHIBITION
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I,3-SULFATE:BUTYROLACTONE I
406182
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM
Aspergillus terreus (HYPHOMYCETES)
ASPULVINONE IASPULVINONE H
293037
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus terreus (HYPHOMYCETES)
TERREULACTONE A
988944
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
1046491
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
CITRININ
328086
PMR SPECTRUM REPORTEDCHEMICAL CONVERSION OFISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus terreus (HYPHOMYCETES)
PLUVINONE,DICYCLO-BIS-(DIMETHYL-ALLYL)-TRIHYDROXY:PLUVINONE,DIHYDROXY:PLUVINONE,MONOCYCLO-BIS-(DIMETHYL-ALLYL)-TRIHYDROXY:PLUVINONE EPOXIDE,MONOCYCLO-BIS-(DIMETHYL-ALLYL)-TRIHYDROXY:PLUVINONE,DICYCLO-BIS-(DIMETHYL-ALLYL)-DIHYDROXY:PLUVINONE,TRIHYDROXY:PLUVINONE,MONOCYCLO-BIS-(DIMETHYL-ALLYL)-DIHYDROXY:
1041863
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus terreus (HYPHOMYCETES)
ITATARTARIC ACIDPARACONIC ACID,BETA-HYDROXY:
51647
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus terreus (HYPHOMYCETES)
ORSELLINIC ACID,3-METHYL:
226133
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aspergillus terreus (HYPHOMYCETES)
KODAISTATIN DKODAISTATIN BKODAISTATIN CKODAISTATIN A
320029
STRUCTURE DETERMINATION OFCMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
TERREIN
922831
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
TERRETONIN
204518
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus terreus (HYPHOMYCETES)
ASTERRIQUINONE CT-5
1003272
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
554406
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
MEVINOLIN
822375
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
TERRETONINAUSTIN
230625
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
230622
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
230621
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I
899258
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
MONACOLIN L
51648
BIOSYNTHESISISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
ORSELLINIC ACID
1030420
PHARMACOLOGY - EFFECT ON PLANTS
MEMBRANE DISRUPTION EFFECT
Aspergillus terreus (HYPHOMYCETES)
621797
ISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
MEVINOLIN
1310354
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I
1046577
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
TERREIN
1145332
PHARMACOLOGY OF COMPOUND - IN VIVO
DIABETOGENIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
768096
QUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
MEVINOLIN
230629
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I
230626
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
321696
ISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
ITACONIC ACID
988945
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus terreus (HYPHOMYCETES)
QUADRONE
31491
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIIMPLANTATION EFFECT
Aspergillus terreus (HYPHOMYCETES)
1051031
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aspergillus terreus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC 14-A
1310356
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLIN DEPENDENT KINASE 1 INHIBITION
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I,4"-SULFATE:
988946
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
QUADRONE
1003271
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
329097
BIOSYNTHESISISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
GEODIN
1003273
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY(PLANT PATHOGEN)
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
587504
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
MEVINOLIN
1003274
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY(PLANT PATHOGEN)
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
230624
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
486897
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
EMODIN
230627
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I
768008
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
MEVINOLIN
204520
PHARMACOLOGY OF COMPOUND - IN VITRO
FACTOR-XA INHIBITION
Aspergillus terreus (HYPHOMYCETES)
ASTERRIQUINONE CT-5
1310357
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I,3-SULFATE:
321796
BIOSYNTHESISISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
PLUVINONE,DIHYDROXY:
293038
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Aspergillus terreus (HYPHOMYCETES)
TERREULACTONE A
1002741
ISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
BENZOQUINONE,1-4-2-METHYL: EPOXIDEBENZOQUINONE,1-4: 2-HYDROXY-3-METHYL:NAPHTHAZARIN EPOXIDETERREIC ACID
995251
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
QUADRONE
329098
BIOSYNTHESISISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
GEODIN,DIHYDRO:
204521
PHARMACOLOGY OF COMPOUND - IN VITRO
TRYPSIN INHIBITION
Aspergillus terreus (HYPHOMYCETES)
ASTERRIQUINONE CT-5
1145331
ISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
226134
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
KODAISTATIN DKODAISTATIN BKODAISTATIN CKODAISTATIN A
848173
PMR SPECTRUM REPORTEDABSOLUTE CONFIGURATION DETERMINEDCD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
TERRECYCLIC ACID A
1015085
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDYPREPARATION OF LABELLLED COMPOUND
Aspergillus terreus (HYPHOMYCETES)
TERREIN
474919
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLINERGIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
TERRITREM B
988943
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
1003270
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID
427076
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus terreus (HYPHOMYCETES)
TERRECYCLIC ACIDQUADRONE
230623
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
204519
PHARMACOLOGY OF COMPOUND - IN VITRO
THROMBIN INHIBITION
Aspergillus terreus (HYPHOMYCETES)
ASTERRIQUINONE CT-5
486896
ISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
EMODINANTHRONE OXIDASE
1310358
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I
668437
IDENTIFICATION IN BY HPLC
Aspergillus terreus (HYPHOMYCETES)
ITACONIC ACID
1310352
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I,3-SULFATE:
1310353
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I,4"-SULFATE:
474918
ISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
TERRITREM B
230628
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Aspergillus terreus (HYPHOMYCETES)
BUTYROLACTONE I
1003275
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
TERREIC ACID